BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28098570)

  • 1. Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas.
    Lapère C; Cortot AB; Grégoire V; Cockenpot V; Tulasne D; Copin MC
    Am J Surg Pathol; 2017 Mar; 41(3):414-422. PubMed ID: 28098570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
    Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
    J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.
    Jurmeister P; Lenze D; Berg E; Mende S; Schäper F; Kellner U; Herbst H; Sers C; Budczies J; Dietel M; Hummel M; von Laffert M
    Lung Cancer; 2015 Feb; 87(2):122-9. PubMed ID: 25534130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.
    Cai YR; Zhang HQ; Qu Y; Mu J; Zhao D; Zhou LJ; Yan H; Ye JW; Liu Y
    Oncol Rep; 2011 Oct; 26(4):877-85. PubMed ID: 21687954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
    Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).
    Casadevall D; Gimeno J; Clavé S; Taus Á; Pijuan L; Arumí M; Lorenzo M; Menéndez S; Cañadas I; Albanell J; Serrano S; Espinet B; Salido M; Arriola E
    Oncotarget; 2015 Jun; 6(18):16215-26. PubMed ID: 26041880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer.
    Saigi M; McLeer-Florin A; Pros E; Nadal E; Brambilla E; Sanchez-Cespedes M
    Clin Transl Oncol; 2018 Jul; 20(7):881-888. PubMed ID: 29139039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
    Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
    J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
    Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH
    J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.
    Mignard X; Ruppert AM; Antoine M; Vasseur J; Girard N; Mazières J; Moro-Sibilot D; Fallet V; Rabbe N; Thivolet-Bejui F; Rouquette I; Lantuejoul S; Cortot A; Saffroy R; Cadranel J; Lemoine A; Wislez M
    J Thorac Oncol; 2018 Dec; 13(12):1962-1967. PubMed ID: 30149144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [c-Met and HGF expression in non-small-cell lung carcinomas].
    Korobko IV; Zinov'eva MV; Allakhverdiev AK; Zborovskaia IB; Svwrdlov ED
    Mol Gen Mikrobiol Virusol; 2007; (2):18-21. PubMed ID: 17598453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.
    Dziadziuszko R; Wynes MW; Singh S; Asuncion BR; Ranger-Moore J; Konopa K; Rzyman W; Szostakiewicz B; Jassem J; Hirsch FR
    J Thorac Oncol; 2012 Feb; 7(2):340-7. PubMed ID: 22237262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
    Zhang X; Li P; Rong M; He R; Hou X; Xie Y; Chen G
    Tohoku J Exp Med; 2015 Mar; 235(3):161-9. PubMed ID: 25746592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
    Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
    J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features and prognostic implications of EGFR/c-Met gene copy number and protein expression in non-small cell lung cancer].
    Ai T; Wang N; Li WW; Song LP
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):825-9. PubMed ID: 21223687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.
    Cabillic F; Gros A; Dugay F; Begueret H; Mesturoux L; Chiforeanu DC; Dufrenot L; Jauffret V; Dachary D; Corre R; Lespagnol A; Soler G; Dagher J; Catros V; Le Calve M; Merlio JP; Belaud-Rotureau MA
    J Thorac Oncol; 2014 Mar; 9(3):295-306. PubMed ID: 24518086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
    J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of CD151 overexpression in non-small cell lung cancer.
    Kwon MJ; Seo J; Kim YJ; Kwon MJ; Choi JY; Kim TE; Lee DH; Park S; Shin YK; Han J; Choi YL
    Lung Cancer; 2013 Jul; 81(1):109-16. PubMed ID: 23570797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.